SCHEMBL29649201

SCHEMBL29649201

O=C1N=NC2=C1CCCCCCCCC2

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 2/20 0.35
TRIM33 Q9UPN9 2/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31058600 0.98 ALDH1A1 (0.33) TRIM24TRIM33ALDH1A1
SCHEMBL7479331 0.97 TRIM24 (0.32) TRIM24TRIM33ALDH1A1
SCHEMBL30995058 0.84 TRIM24 (0.43) TRIM24TRIM33ALDH1A1
SCHEMBL7953954 0.67
SCHEMBL4309011 0.64 TRIM24 (0.39) TRIM24TRIM33ALDH1A1
SCHEMBL18642871 0.62 TRIM24 (0.50) TRIM24TRIM33ALDH1A1
SCHEMBL18642898 0.60 TRIM24 (0.47) TRIM24TRIM33ALDH1A1
SCHEMBL31377549 0.59
SCHEMBL10638515 0.58 TRIM24 (0.47) TRIM24TRIM33ALDH1A1
SCHEMBL10363679 0.58 CRBN (0.33) TRIM24TRIM33ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119522227-A Macrocyclic compounds, pharmaceutical compositions and uses thereof 贝达药业股份有限公司 2025-02-25 CN claimed
WO-2024017358-A1 MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 贝达药业股份有限公司 2024-01-25 WO claimed
CN-119522227-A Macrocyclic compounds, pharmaceutical compositions and uses thereof 贝达药业股份有限公司 2025-02-25 CN disclosed
CN-113527335-B Macrocyclic compound as EGFR inhibitor and application thereof 南京圣和药业股份有限公司 2025-02-11 CN disclosed
CN-118488958-A Compounds for degrading EGFR kinase 百济神州有限公司 2024-08-13 CN disclosed
WO-2024017358-A1 MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 贝达药业股份有限公司 2024-01-25 WO disclosed
WO-2022135432-A1 MACROCYCLIC HETEROCYCLIC COMPOUNDS AS EGFR INHIBITORS, AND USE THEREOF 南京圣和药业股份有限公司 2022-06-30 WO disclosed
WO-2022117051-A1 MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 北京鞍石生物科技有限责任公司 2022-06-09 WO disclosed